Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130206009M |
| Application |
Infection |
The kit has been designed for the quantitative determination of Troponin I (high sensitive) in human serum. The method can be used for samples over the range of 0-50ng/ml. The test has to be performed on the MAGLUMI chemiluminescence immunoassay (CLIA) fully auto analyzer (Including MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus and new developed models).
Precision Cardiac Biomarker AnalysisSnibe MAGLUMI S-Troponin I enables laboratories to provide accurate, real-time cardiac biomarker detection for rapid clinical decision-making. Its advanced chemiluminescence technology and automated process ensure dependable results for patient management in acute cardiovascular emergencies.
User-Friendly and Reliable PerformanceDesigned with convenience in mind, the kit comes as a ready-to-use liquid format, requiring no elaborate preparation. Automated operation on the MAGLUMI analyzers ensures ease of use, minimal hands-on time, and consistent performance within a 12-month shelf life.
Adaptable to Laboratory WorkflowsThe reagent kit is suitable for diverse laboratory environments across India, serving dealers, suppliers, and healthcare facilities. Its compatibility with all MAGLUMI analyzers and standard storage conditions (2-8C) makes it accessible and flexible for varying testing volumes.
FAQ's of Snibe MAGLUMI S-Troponin I (CLIA):
Q: How does the Snibe MAGLUMI S-Troponin I (CLIA) detect Troponin I in samples?
A: The kit uses a two-site sandwich chemiluminescence immunoassay, which specifically binds S-Troponin I in human serum or plasma, allowing quantitative detection through MAGLUMI automated immunoassay analyzers.
Q: What is the recommended calibration schedule for this test kit?
A: Calibration should be performed according to analyzer guidelines, typically every 28 days or more frequently as indicated by quality control results.
Q: Where is the Snibe MAGLUMI S-Troponin I kit typically used?
A: This reagent kit is intended for use in clinical laboratories equipped with MAGLUMI Series Automated Immunoassay Analyzers. It is not portable and is suitable for in-vitro diagnostic use in hospitals and diagnostic centers.
Q: When can test results be expected after sample loading?
A: Results are typically available in about 18 minutes per test cycle when running on a MAGLUMI platform.
Q: What are the benefits of using this kit for acute myocardial infarction management?
A: It provides high sensitivity and reliability, enabling early detection of cardiac events. Fast turnaround times support prompt clinical assessment and improved patient outcomes.
Q: How should the reagent kit be stored to maintain stability?
A: The reagents should be stored at 2-8C, avoiding freezing, to ensure optimal shelf life and assay performance.